Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Risk Factors, Treatment and Outcome of 2 nd Relapse of Acute Lymphoblastic Leukemia in Children. Results of the ALL-REZ BFM Registry

Junko Yamanaka, MD, Valentijn Bon, André Schrauder, Christina Peters, MD, Günter Henze, MD, Arend von Stackelberg, MD

Blood (2012) 120 (21): 668.

https://doi.org/10.1182/blood.V120.21.668.668

Published: 2012

Journal Articles

Conventional Reinduction/Consolidation-Type Therapy Versus Short Course High Intensity Combination Chemotherapy As Post-Induction Treatment for Children with Relapsed Acute Lymphoblastic Leukemia. Early Results of Study ALL-REZ BFM 2002

Arend von Stackelberg, MD, Junko Yamanaka, MD, Gabriele Escherich, MD, Cornelia Eckert, PhD, Richard Ratei, MD, Johann K. Hitzler, MD, Georg Mann, MD, Lucie Sramkova, MD, Jean-Pierre Bourquin, MD, PhD, Martin Schrappe, MD, Günter Henze, MD

Blood (2011) 118 (21): 871.

https://doi.org/10.1182/blood.V118.21.871.871

Published: 2011

Journal Articles

Therapeutic Efficacy of Natural Compounds From Viscum Album l. In Acute Lymphoblastic Leukemia

Catharina I. Delebinski, Sebastian Jaeger, Kristin Kemnitz-Hassanin, Arend von Stackelberg, MD, Günter Henze, Holger N. Lode, Georg Seifert

Blood (2010) 116 (21): 3261.

https://doi.org/10.1182/blood.V116.21.3261.3261

Published: 2010

Journal Articles

Acute Lymphoblastic Leukemia in a Case of Ring Chromosome

Seval Türkmen, Sebastian Muller, Stefan Mundlos, Günter Henze, Holger Lode

Blood (2008) 112 (11): 4151.

https://doi.org/10.1182/blood.V112.11.4151.4151

Published: 2008

Journal Articles

Risk-Adjusted Therapy of Acute Lymphoblastic Leukemia Can Decrease Treatment Burden and Improve Survival: Treatment Results of 2169 Unselected Pediatric and Adolescent Patients Enrolled in the Trial ALL-BFM 95.

Anja Möricke, MD, Alfred Reiter, MD, Martin Zimmermann, PhD, Helmut Gadner, MD, Martin Stanulla, MD, Wolf-Dieter Ludwig, MD, Jochen Harbott, PhD, Georg Mann, MD, Felix Niggli, MD, Günter Henze, MD, Karl Welte, MD, Thomas Klingebiel, MD, Charlotte Niemeyer, MD, Felix Zintl, MD, Hansjörg Riehm, MD, Martin Schrappe, MD

Blood (2007) 110 (11): 584.

https://doi.org/10.1182/blood.V110.11.584.584

Published: 2007

Journal Articles

BCR-ABL Specific Sequences Are Required To Prevent Ph + Acute Lymphoblastic Leukemia in Syngeneic Mice by DNA Vaccination.

Joachim Köchling, Javier Prada, Masoud Bahrami, Sven A. König Merediz, Renata Stripecke, Karl Seeger, Günter Henze, Burghardt Wittig, Manuel Schmidt

Blood (2006) 108 (11): 3262.

https://doi.org/10.1182/blood.V108.11.3262.3262

Published: 2006

Journal Articles

Sensitivity of Childhood Acute Lymphoblastic Leukemia (ALL) to Idarubicin Is Significantly Higher Than to Daunorubicin Treatment Based on Ex Vivo Apoptosis Induction.

Aram Prokop, MD, PhD, Banu Bagci, Guenaelle Lingfeld, MD, Lucia Badiali, Karin Garbrecht, Ulrike Mietzsch, MD, Thomas Wieder, PhD, Peter T. Daniel, MD, Günter Henze, MD

Blood (2004) 104 (11): 4495.

https://doi.org/10.1182/blood.V104.11.4495.4495

Published: 2004

Journal Articles

Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis

Anja Borgmann, Arend von Stackelberg, Reinhard Hartmann, Wolfram Ebell, Thomas Klingebiel, Christina Peters, Günter Henze

Blood (2003) 101 (10): 3835–3839.

https://doi.org/10.1182/blood.V101.10.3835

Published: 2003

Journal Articles

Deletion analysis of p16 INKa and p15 INKb in relapsed childhood acute lymphoblastic leukemia

Hagen Graf Einsiedel, Tillmann Taube, Reinhard Hartmann, Sven Wellmann, Georg Seifert, Günter Henze, Karl Seeger

Blood (2002) 99 (12): 4629–4631.

https://doi.org/10.1182/blood.V99.12.4629

Published: 2002

Journal Articles

Traumatic lumbar puncture at diagnosis and outcome in childhood acute lymphoblastic leukemia

Christian Kebelmann-Betzing, Karlheinz Seeger, Renate Wolf, Günter Henze

Blood (2001) 98 (12): 3496–3497.

https://doi.org/10.1182/blood.V98.12.3496

Published: 2001

Journal Articles

Prognostic value of p16 INK4a gene deletions in pediatric acute lymphoblastic leukemia

Hagen Graf Einsiedel, Tillmann Taube, Reinhard Hartmann, Cornelia Eckert, Georg Seifert, Sven Wellmann, Günter Henze, Karl Seeger

Blood (2001) 97 (12): 4002–4004.

https://doi.org/10.1182/blood.V97.12.4002

Published: 2001

Journal Articles

Oral isobutyramide reduces transfusion requirements in some patients with homozygous β-thalassemia

Susanne Reich, Christoph Bührer, Günter Henze, Dieter Ohlendorf, Michael Mesche, Pranav Sinha, Andreas Kage, Christian Müller, Barbara Vetter, Andreas E. Kulozik

Blood (2000) 96 (10): 3357–3363.

https://doi.org/10.1182/blood.V96.10.3357

Published: 2000

Journal Articles

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90

Martin Schrappe, Alfred Reiter, Wolf-Dieter Ludwig, Jochen Harbott, Martin Zimmermann, Wolfgang Hiddemann, Charlotte Niemeyer, Günter Henze, Andreas Feldges, Felix Zintl, Bernhard Kornhuber, Jörg Ritter, Karl Welte, Helmut Gadner, Hansjörg Riehm

Blood (2000) 95 (11): 3310–3322.

https://doi.org/10.1182/blood.V95.11.3310

Published: 2000

Journal Articles

Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy

Lutz Löning, Martin Zimmermann, Alfred Reiter, Peter Kaatsch, Günter Henze, Hansjörg Riehm, Martin Schrappe

Blood (2000) 95 (9): 2770–2775.

https://doi.org/10.1182/blood.V95.9.2770.009k16_2770_2775

Published: 2000

Journal Articles

Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Group report

Alfred Reiter, Martin Schrappe, Wolf-Dieter Ludwig, Markus Tiemann, Reza Parwaresch, Martin Zimmermann, Eckard Schirg, Günter Henze, Günther Schellong, Helmut Gadner, Hansjörg Riehm

Blood (2000) 95 (2): 416–421.

https://doi.org/10.1182/blood.V95.2.416

Published: 2000

Journal Articles

Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

Alfred Reiter, Martin Schrappe, Markus Tiemann, Wolf-Dieter Ludwig, Elif Yakisan, Martin Zimmermann, Georg Mann, Andreas Chott, Wolfram Ebell, Thomas Klingebiel, Norbert Graf, Bernhard Kremens, Stefan Müller-Weihrich, Hans-Jürgen Plüss, Felix Zintl, Günter Henze, Hansjörg Riehm

Blood (1999) 94 (10): 3294–3306.

https://doi.org/10.1182/blood.V94.10.3294.422k12_3294_3306

Published: 1999

Journal Articles

TEL-AML1 Fusion in Relapsed Childhood Acute Lymphoblastic Leukemia

Karlheinz Seeger, Dirk Buchwald, Anita Peter, Tillmann Taube, Arend von Stackelberg, Gabriele Schmitt, Günter Henze

Blood (1999) 94 (1): 374–376.

https://doi.org/10.1182/blood.V94.1.374.413a48c_374_376

Published: 1999

Journal Articles

TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia

Karlheinz Seeger, Hans-Peter Adams, Dirk Buchwald, Birgit Beyermann, Bernhard Kremens, Charlotte Niemeyer, Jörg Ritter, Dirk Schwabe, Dörte Harms, Martin Schrappe, Günter Henze

Blood (1998) 91 (5): 1716–1722.

https://doi.org/10.1182/blood.V91.5.1716

Published: 1998

NARROW

Risk Factors, Treatment and Outcome of 2 nd Relapse of Acute Lymphoblastic Leukemia in Children. Results of the ALL-REZ BFM Registry

Conventional Reinduction/Consolidation-Type Therapy Versus Short Course High Intensity Combination Chemotherapy As Post-Induction Treatment for Children with Relapsed Acute Lymphoblastic Leukemia. Early Results of Study ALL-REZ BFM 2002

Therapeutic Efficacy of Natural Compounds From Viscum Album l. In Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia in a Case of Ring Chromosome

Risk-Adjusted Therapy of Acute Lymphoblastic Leukemia Can Decrease Treatment Burden and Improve Survival: Treatment Results of 2169 Unselected Pediatric and Adolescent Patients Enrolled in the Trial ALL-BFM 95.

BCR-ABL Specific Sequences Are Required To Prevent Ph + Acute Lymphoblastic Leukemia in Syngeneic Mice by DNA Vaccination.

Sensitivity of Childhood Acute Lymphoblastic Leukemia (ALL) to Idarubicin Is Significantly Higher Than to Daunorubicin Treatment Based on Ex Vivo Apoptosis Induction.

Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis

Deletion analysis of p16 INKa and p15 INKb in relapsed childhood acute lymphoblastic leukemia

Traumatic lumbar puncture at diagnosis and outcome in childhood acute lymphoblastic leukemia

Prognostic value of p16 INK4a gene deletions in pediatric acute lymphoblastic leukemia

Oral isobutyramide reduces transfusion requirements in some patients with homozygous β-thalassemia

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90

Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy

Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Group report

Improved Treatment Results in Childhood B-Cell Neoplasms With Tailored Intensification of Therapy: A Report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90

TEL-AML1 Fusion in Relapsed Childhood Acute Lymphoblastic Leukemia

TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only